Simplify Logo
Solventum

Solventum

Global healthcare company: wound care, dental

Adoption Specialist

Full-Time
No salary listed
Mid, Senior
Bachelor's
Belmont, Australia+4 more

More locations: Brisbane QLD, Australia | Melbourne VIC, Australia | Sydney NSW, Australia | Edinburgh, Australia

Remote

Remote-based with occasional on-site visits; ~30-40% travel.

About the job

Requirements
  • Educated to a high level, preferably degree-qualified, or equivalent relevant experience
  • 5+ years in a clinical outpatient/inpatient environment working with medical transcription and/or speech recognition technologies in direct clinician contact and support roles
  • Nursing experience preferred
  • Experience working with EMR environments and medical transcription technology
  • 3–5 years as a solutions instructor and/or trainer
  • Background in healthcare or healthcare IT, with knowledge of clinical workflows and clinical documentation/improvement processes
  • Skilled in delivering both in-person and virtual training sessions; confident running sessions or demos for physicians and other clinical stakeholders
  • Experience managing multiple customers/accounts concurrently and working with diverse stakeholder groups
  • Familiarity with the Australian public/private healthcare system and Medicare reimbursements
  • Experience working with PHI and using or learning internal support/ticketing systems
  • Excellent written and verbal communication skills
  • Quick learner, adept at adopting new technologies and skills
  • Proficient in Microsoft Word, Excel, and PowerPoint
  • Strong problem-solving, critical thinking, and listening skills
  • Able to work under challenging deadlines with a positive approach
  • Strong organisational skills with the ability to prioritise and follow through on multiple tasks
  • Ability to explain technical instructions to users of varying technical proficiency
  • Proven follow-through on issues with an emphasis on creating preventative processes and tools
  • Skilled at building meaningful, trust-based relationships with customers
  • Collaborative team player with a service-oriented mindset
  • Approximately 30-40% travel
Responsibilities
  • The Adoption Specialist’s primary responsibility is to drive the success of Solventum clinician-facing technologies by maximising user adoption, satisfaction, education, and measurable customer benefits, based on usage statistics and customer feedback. In doing so, the Adoption Specialist works in coordination with the Solventum project team and manages relationships with end-users (e.g. clinicians, administrators, trainers, and other identified stakeholders)
  • Responsible for onsite or virtual optimisation deliverables (e.g. customised training documents, webinar sessions, and/or training videos), ranging from at-the-elbow end-user training to workflow reviews, to identify opportunities for solution enhancements
  • Collaborates with Project Managers, Solution Architects, Technical, Support, and Implementation Specialists to ensure effective project delivery and adoption outcomes
  • Takes operational ownership of assigned customer accounts from project closure through to the end of the contract, acting as their success manager
  • Works alongside the project team during implementation until closure, then assumes full account responsibility post-closure
  • Identifies, documents, and communicates customer requirements through discovery sessions, working with the implementation team to address needs
  • Supports Customer Support functions, including triaging the support inbox, managing imaging-related queries, addressing training gaps, reinforcing speech recognition best practices, and responding to general questions or technical issues
  • Builds strong, ongoing relationships with assigned accounts, ensuring customers have a clear and trusted main point of contact post-project
  • Operates within a buddy/backup system to ensure seamless account coverage during leave or unavailability, keeping the backup Adoption Specialist informed and prepared
  • Drive user adoption, satisfaction, and benefits for Solventum clinician-facing solutions through tailored training, workflow optimisation, and usage analysis
  • Deliver onsite/virtual training (webinars, at-the-elbow, group sessions, videos) during go-live and post-go-live phases
  • Review adoption data with customers, recommend improvements, and track follow-up actions
  • Maintain strong relationships with assigned accounts as primary post-project contact, ensuring seamless communication and timely follow-up
  • Collaborate with project, support, and product teams to resolve issues, address product gaps, and identify enhancement opportunities
  • Troubleshoot and prioritise speech recognition issues, liaising with the speech development team
  • Maintain accurate account documentation, report status to stakeholders, and schedule site visits as required
  • Act as the voice of the customer for technical issues and product improvements

About the company

Solventum provides a wide range of healthcare products across four main areas: wound care and surgical supplies, dental and orthodontic tools, health information software, and purification filters for biopharmaceuticals. These products work by combining material science and data science to help hospitals manage patient records, prevent infections during surgery, and filter fluids for medical treatments like dialysis. Unlike many competitors, the company holds a massive portfolio of over 7,300 patents inherited from its history as a 3M division, allowing it to serve over 75% of U.S. hospitals. Its goal is to use this intellectual property and a disciplined business model to find new solutions for healthcare providers and grow within the global medical technology market.

Company Size

10,001+

Company Stage

IPO

Headquarters

Maplewood, Minnesota

Founded

2023

Get referred to Solventum

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Q2 2026 organic sales rose 9.5%, and management lifted EPS guidance to $7.10-$7.20.
  • Dental grew 15.2% organically in Q2 2026, showing pricing and product momentum.
  • Solventum exited nearly 70% of TSAs and targets 90% by end-2026.

What critics are saying

  • ERP advance orders inflated Q2 by about $125 million, and Q3 reverses.
  • HIS now faces separation, and AI-native competitors threaten revenue-cycle workflows by 2027.
  • Thermo Fisher's $4.1 billion filtration acquisition removes Solventum's fastest-growing cash engine.

What makes Solventum unique

  • Solventum controls 3M-origin IP, with 7,300 patents across MedSurg, dental, and filtration.
  • Its $200 million Eagan Innovation Hub centralizes wound care, sterilization, and digital health R&D.
  • Management expects nearly 20 launches through Q1 2028, anchoring category depth.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Health Savings Account/Flexible Spending Account

Remote Work Options

Paid Vacation

Paid Sick Leave

Paid Holidays

Hybrid Work Options

Relocation Assistance

Growth & Insights and Company News

Headcount

6 month growth

5%

1 year growth

5%

2 year growth

8%
Yahoo Finance
Aug 20th, 2026
BrightSpring Health Services posts 23.9% revenue growth as Solventum and Inspire Medical face headwinds

BrightSpring Health Services stands out as a strong long-term healthcare investment, whilst Solventum and Inspire Medical Systems face headwinds, according to recent analysis. Healthcare stocks have surged 27.5% over the past six months, outperforming the S&P 500 by 16.2 percentage points. However, increased venture capital has intensified competition across the sector. BrightSpring, which provides home health care, hospice, and pharmacy services, has achieved 23.9% annual revenue growth over the past two years. Analysts forecast 14.1% revenue growth for the next 12 months. Conversely, Solventum faces weak demand with flat revenue expected, whilst its free cash flow margin has declined 18.2 percentage points over five years. Inspire Medical Systems confronts a forecasted revenue decline of 3.5% for the upcoming year.

Yahoo Finance
Aug 11th, 2026
Solventum beats Q2 estimates with $2.21B revenue, raises EPS guidance 10% amid HIS separation

Healthcare solutions provider Solventum reported second quarter revenue of $2.21 billion, up 2.2% year on year and ahead of analyst estimates of $2.15 billion. Non-GAAP profit of $2.55 per share beat consensus estimates by 33.8%. The company announced plans to separate its Health Information Systems business to focus on its MedSurg and Dental segments. Management said the move would allow the HIS unit to pursue AI-driven innovation whilst sharpening Solventum's focus as a pure-play MedTech company. Second quarter results were temporarily boosted by approximately $125 million in advanced orders placed ahead of a major ERP system transition, which management expects to reverse next quarter. The company raised its full-year adjusted EPS guidance to $7.15 at the midpoint, a 10% increase. Solventum is nearing completion of its separation from 3M.

Yahoo Finance
Aug 9th, 2026
Solventum raises 2026 outlook with 9.5% Q2 growth boosted by $125M advanced orders and $100M tariff refund

Solventum exceeded expectations in Q2, posting $2.2 billion in sales with 9.5% organic growth. However, this included roughly $125 million in advanced ERP-related orders and a $100 million tariff refund. Excluding these benefits, organic growth was approximately 4% and adjusted EPS was estimated at $1.73. The company raised its 2026 outlook, now expecting 2.5%–3% organic sales growth, a 22.2%–22.7% operating margin, adjusted EPS of $7.10–$7.20, and free cash flow of $200 million–$300 million. Third-quarter growth is expected to decline temporarily as the advanced orders reverse. Solventum also announced plans to separate its Health Information Systems business through a potential spin-off or sale, aiming to focus on its MedSurg and Dental segments.

PR Newswire
Aug 5th, 2026
Solventum Q2 sales up 9.5%, raises 2026 guidance and plans to separate Health Information Systems unit

Solventum reported second quarter 2026 sales of $2.2 billion, up 2.2% on a reported basis and 9.5% organically. The MedTech company posted GAAP diluted earnings per share of $0.53 and adjusted diluted EPS of $2.55, marking a 50.9% increase. Operating cash flow reached $227 million, whilst free cash flow totalled $144 million. The strong performance was driven by volume and product mix across all segments, including advance orders ahead of ERP cutovers. Solventum announced plans to separate its Health Information Systems business segment as part of its transformation strategy. The company raised its full-year 2026 guidance, increasing organic sales growth to 2.5% to 3.0%, adjusted EPS to $7.10 to $7.20, and free cash flow to $200 million to $300 million.

Yahoo Finance
Aug 2nd, 2026
Solventum appoints Neil Zieselman as chief accounting officer

Solventum has appointed Neil Zieselman as Senior Vice President, Controller, and Chief Accounting Officer. He will succeed Mary Wilcox, who is retiring. Zieselman brings experience from Surgery Partners, Stryker Corporation, Covanta Holding Corporation, Cendant Corporation, and Avaya. He is a licensed CPA. The company's stock trades at $85.44. It has delivered a 9.5% return over the past week and 19.1% over the past year. For investors, Zieselman's background in healthcare and corporate finance may influence Solventum's financial controls, reporting quality, and regulatory engagement. His approach could shape disclosure practices and capital allocation commentary in future earnings calls. Interest payments are not well covered by earnings, making any changes under the new Chief Accounting Officer particularly important for risk assessment.